Candido Gude

Statistics

Publications

Citations

933

H-Index

Active since

1983

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Novartis (Switzerland)

Tris Pharma (United States)

Merck, S.L.U. (Spain)

United States Military Academy

Candido Gude is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacology, and enzyme inhibition.

Publications per year

1983–2014

Publications

Fadrozole hydrochloride: a potent, selective, nonsteroidal inhibitor of aromatase for the treatment of estrogen-dependent disease

Leslie J. Browne, Candido Gude, Ronald E. Steele et al. · Journal of Medicinal Chemistry · 1991 · 224 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®

Timothy A. Blizzard, Helen Chen, Seongkon Kim et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 161 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors

Neville F. Ford, Leslie J. Browne, Thomas Campbell et al. · Journal of Medicinal Chemistry · 1985 · 106 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +5

Angiotensin converting enzyme inhibitors: 1-glutarylindoline-2-carboxylic acid derivatives

Norbert Gruenfeld, James L. Stanton, Andrew Yuan et al. · Journal of Medicinal Chemistry · 1983 · 76 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Synthesis of 4-substituted phenylalanines by cross-coupling reactions: Extension of the methodology to aryl chlorides

Fariborz Firooznia, Candido Gude, Kenneth Chan et al. · Tetrahedron Letters · 1998 · 63 citations

Natural Sciences, Chemistry, Medicinal Chemistry +9

1–5 of 19